Advancements in Translational Biomarker Identification from Cell-Free RNA
Liquid biopsy is most often associated with cell-free DNA, but new research has shown additional value in interrogating a broader diversity of analytes in the blood.
Cell-free RNA (cfRNA) is one such molecule that has been shown to reflect dynamic changes in many tissues. Researchers at Illumina have optimized key variables to enable scalable, end-to-end workflow solutions for whole-transcriptome library preparations of cfRNA.
Continued application of cfRNA stands to benefit a multitude of human health concerns by empowering non-invasive interrogations of disease etiology and identification of predictive, diagnostic, and prognostic biomarkers, all of which will further facilitate our transition into the era of personalized medicine.
#liquidbiopsy #rna #rnaseq #sequencing #transcription
Resources:
Paper referred to in video - https://www.science.org/doi/10.1126/scitranslmed.aaz0131
RNA prep with Enrichment - https://www.illumina.com/products/by-type/sequencing-kits/library-prep-kits/rna-prep-enrichment.html
Presenters:
Dan Gheba – Executive Sequencing Specialist, Illumina
Suzanne Rohrback PhD – Senior Scientist, Advanced Sciences, Illumina
00:00 Introduction to Liquid Biopsy
01:25 Why RNA over DNA?
04:24 Illumina cfRNA Study Introduction
05:43 cfRNA quality and method development
08:52 Sample Collection best practices
10:50 Study findings – unique biomarkers
14:24 Machine learning model
16:52 Method Update!
19:09 Publication Summary
20:28 How can you use cfRNA in your research?
Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79
View Illumina webinars
https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ
View Illumina product videos
https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd
View Illumina support videos
https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM
Видео Advancements in Translational Biomarker Identification from Cell-Free RNA канала Illumina
Cell-free RNA (cfRNA) is one such molecule that has been shown to reflect dynamic changes in many tissues. Researchers at Illumina have optimized key variables to enable scalable, end-to-end workflow solutions for whole-transcriptome library preparations of cfRNA.
Continued application of cfRNA stands to benefit a multitude of human health concerns by empowering non-invasive interrogations of disease etiology and identification of predictive, diagnostic, and prognostic biomarkers, all of which will further facilitate our transition into the era of personalized medicine.
#liquidbiopsy #rna #rnaseq #sequencing #transcription
Resources:
Paper referred to in video - https://www.science.org/doi/10.1126/scitranslmed.aaz0131
RNA prep with Enrichment - https://www.illumina.com/products/by-type/sequencing-kits/library-prep-kits/rna-prep-enrichment.html
Presenters:
Dan Gheba – Executive Sequencing Specialist, Illumina
Suzanne Rohrback PhD – Senior Scientist, Advanced Sciences, Illumina
00:00 Introduction to Liquid Biopsy
01:25 Why RNA over DNA?
04:24 Illumina cfRNA Study Introduction
05:43 cfRNA quality and method development
08:52 Sample Collection best practices
10:50 Study findings – unique biomarkers
14:24 Machine learning model
16:52 Method Update!
19:09 Publication Summary
20:28 How can you use cfRNA in your research?
Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79
View Illumina webinars
https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ
View Illumina product videos
https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd
View Illumina support videos
https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM
Видео Advancements in Translational Biomarker Identification from Cell-Free RNA канала Illumina
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![An Overview of MyIllumina & B2B eProcurement Solutions](https://i.ytimg.com/vi/O1dZQTTKJIU/default.jpg)
![Connecting More Learners to Genomics through Teachers](https://i.ytimg.com/vi/hX9hVGc9m5Y/default.jpg)
![Microbial Genomics of Extremely Polluted Environments - Adventures in Genomics](https://i.ytimg.com/vi/mhHdbjgX1LM/default.jpg)
![Taking a Genome-First Approach](https://i.ytimg.com/vi/-x2XSvWX_NY/default.jpg)
![Illumina Genomics Forum: What Genomics Help Us See with Bill Gates](https://i.ytimg.com/vi/gnfQKAVP6cc/default.jpg)
![Hear from our customers what value Illumina’s VeriSeq™NIPT Solution v2 brings to their lab](https://i.ytimg.com/vi/ZqsotN0Jyv0/default.jpg)
![Michael Rossi: Advancing Clinical Cancer Research With NGS](https://i.ytimg.com/vi/InWtGqwaNgo/default.jpg)
![Disruption Ahead](https://i.ytimg.com/vi/OJZc4AYOrmY/default.jpg)
![Health Management – Operationalizing Genomic Healthcare](https://i.ytimg.com/vi/dR0s3ipLzQ4/default.jpg)
![Tertiary Analysis with BaseSpace® Variant Interpreter: AmpliSeqTM for Illumina®](https://i.ytimg.com/vi/TDbdXG3jB8U/default.jpg)
![Attack of the Jet-Lagged Tomatoes](https://i.ytimg.com/vi/AjJiEZNji9k/default.jpg)
![Interpretation der Ergebnisse eines nichtinvasiven Pränataltests (NIPT)](https://i.ytimg.com/vi/IthLLjSg8KE/default.jpg)
![Architecting the Health's Radically New Infrastructure](https://i.ytimg.com/vi/1qsnSWkqxcA/default.jpg)
![How to Use the Cartridge Recycling Tool for NextSeq 1000/2000](https://i.ytimg.com/vi/AdZEZXjOmKU/default.jpg)
![Genomics in Oncology Summit - ImmunoOncology Lecture Series Teaser](https://i.ytimg.com/vi/RZraMPS0qYM/default.jpg)
![Discovering a Causal Somatic Mutation in Patients with Sturge-Weber](https://i.ytimg.com/vi/1eqWItMiVWI/default.jpg)
![Expanding Environmental DNA Research at Jonah Ventures](https://i.ytimg.com/vi/pktFDxm2fZI/default.jpg)
![Illumina Connected Analytics Cohorts: Multi-Omic Cancer Workflow](https://i.ytimg.com/vi/wr19Y8BVaQ4/default.jpg)
![Collaboration and Innovation Define the Precision Medicine Playbook](https://i.ytimg.com/vi/jPQLCe1BMA8/default.jpg)
![Illumina Agrigenomic Solutions | Illumina Video](https://i.ytimg.com/vi/IG3KJwPNeMQ/default.jpg)
![CSR at Illumina](https://i.ytimg.com/vi/tcR0bFv2dTw/default.jpg)